Details of the Drug Combinations

General Information of This Drug (ID: DMVP5YE)

Drug Name

Doxorubicin DMVP5YE

Synonyms

doxorubicin; 23214-92-8; Doxil; Doxorubicine; Adriablastin; Doxorubicinum; 14-Hydroxydaunomycin; 14-Hydroxydaunorubicine; Doxorubicina; Adriamycin semiquinone; Doxorubicinum [INN-Latin]; Doxorubicine [INN-French]; Doxorubicina [INN-Spanish]; Myocet; FI 106; Doxorubicin [USAN:INN:BAN]; CCRIS 739; NDC 38242-874; HSDB 3070; UNII-80168379AG; NCI-C01514; EINECS 245-495-6; CHEMBL53463; CHEBI:28748; 5,12-Naphthacenedione,; ADM; ADR; ThermoDox; Aerosolized Doxorubicin; Doxorubicin citrate; RDF Rubex; Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74; DM2; JT9100000; Adiblastine (hydrochloride salt); Adr iablatina (hydrochloride salt); Adriablastine (hydrochloride salt); Adriablatina (hydrochloride salt); Adriacin (hydrochloride salt); Adriamycin PFS (TN); Adriamycin PFS (hydrochloride salt); Adriamycin RDF (TN); Adriamycin RDF (hydrochloride salt); Adriblastina (TN); Adriblastina (hydrochloride salt); Adriblatina (hydrochloride salt); Caelyx (TN); Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120; DOX-SL; Doxorubicin hydrochloride (hydrochloride salt); Doxorubicin-hLL1; Doxorubicin-hLL1 conjugate; Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochlor ide (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); Myocet (TN); Rubex (TN); Rubex (hydrochloride salt); TLC D-99; Doxorubicin (USAN/INN); Doxorubicin-P4/D10; Doxorubicin-P4/D10 conjugate; Cantide + adriamycin

Indication

Disease Entry	ICD 11	Status	REF
Acute myelogenous leukaemia	2A41	Approved	[1]
Adult kidney Wilms tumor	N.A.	Approved	[1]
Anterior urethra cancer	N.A.	Approved	[1]
Beckwith-Wiedemann syndrome	N.A.	Approved	[1]
Breast carcinoma	N.A.	Approved	[1]
Burkitt lymphoma	N.A.	Approved	[1]
Carcinoma	2A00-2F9Z	Approved	[1]
Childhood kidney Wilms tumor	N.A.	Approved	[1]
Epithelial ovarian cancer	2B5D	Approved	[1]
Fallopian tube neoplasm	N.A.	Approved	[1]
Hamartoma	N.A.	Approved	[1]
Hormone-resistant prostate carcinoma	N.A.	Approved	[1]
Inflammatory breast cancer	2C62	Approved	[1]
Kaposi sarcoma	2B57	Approved	[1]
Kidney neoplasm	N.A.	Approved	[1]
Leukemia	N.A.	Approved	[1]
Lung cancer	2C25.0	Approved	[1]
MALT lymphoma	N.A.	Approved	[1]
Nodal marginal zone lymphoma	2A85.0	Approved	[1]
Ovarian disorder	N.A.	Approved	[1]
Ovarian neoplasm	N.A.	Approved	[1]
Plasma cell myeloma	2A83.1	Approved	[1]
Posterior urethra cancer	N.A.	Approved	[1]
Primary systemic amyloidosis	N.A.	Approved	[1]
Small-cell lung cancer	2C25.Y	Approved	[1]
Solid tumour/cancer	2A00-2F9Z	Approved	[2]
Splenic marginal zone lymphoma	N.A.	Approved	[1]
Testicular lymphoma	N.A.	Approved	[1]
Thyroid cancer	2D10	Approved	[1]
Wilms tumor	N.A.	Approved	[1]
Hepatocellular carcinoma	2C12.02	Phase 3	[3]
Breast cancer	2C60-2C65	Phase 2	[4]
Classic Hodgkin lymphoma	N.A.	Investigative	[1]
Follicular lymphoma	2A80	Investigative	[1]
Neuroblastoma	2D11.2	Investigative	[1]
Tumour	2A00-2F9Z	Investigative	[5]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Therapeutic Class

Anticancer Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

493 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
10-hydroxycamptothecin + Doxorubicin	DCL4NCM	10-hydroxycamptothecin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Abexinostat + Doxorubicin	DC9ET99	Abexinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
ABT-263 + Doxorubicin	DC7FKC1	ABT-263	Ewing sarcoma (Cell Line: TC-71)	[7]
Acarbose + Doxorubicin	DCEC4N8	Acarbose	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Acetazolamide + Doxorubicin	DCS5ATN	Acetazolamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Aliskiren + Doxorubicin	DCEZDD4	Aliskiren	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Allopurinol + Doxorubicin	DCJIIQX	Allopurinol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Amiloride + Doxorubicin	DC9GQSU	Amiloride	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Amodiaquine + Doxorubicin	DCFLYC6	Amodiaquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Armodafinil + Doxorubicin	DC2KU6U	Armodafinil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
AS-1949490 + Doxorubicin	DCDQKGA	AS-1949490	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Asenapine + Doxorubicin	DCL8LNK	Asenapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Azatadine + Doxorubicin	DC2ZHYA	Azatadine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Bafilomycin A1 + Doxorubicin	DCCWL56	Bafilomycin A1	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
BHV-0223 + Doxorubicin	DC6UIXQ	BHV-0223	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Bortezomib + Doxorubicin	DCWUB33	Bortezomib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Bosentan + Doxorubicin	DCVFG4D	Bosentan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Busulfan + Doxorubicin	DCK47OA	Busulfan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Carglumic acid + Doxorubicin	DC4O5X5	Carglumic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Cevimeline + Doxorubicin	DCYRUQR	Cevimeline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Chlorambucil + Doxorubicin	DC68WQ2	Chlorambucil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Chlormezanone + Doxorubicin	DCJTXX4	Chlormezanone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Chloroquine + Doxorubicin	DC8C4SZ	Chloroquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Cinacalcet + Doxorubicin	DCY4GNS	Cinacalcet	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Cisatracurium + Doxorubicin	DCMHUV4	Cisatracurium	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Citarinostat + Doxorubicin	DC6KYXT	Citarinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Clopidogrel + Doxorubicin	DC844NY	Clopidogrel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Dactinomycin + Doxorubicin	DCMLEFV	Dactinomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[7]
Dantrolene + Doxorubicin	DCSLN3G	Dantrolene	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Dichlorphenamide + Doxorubicin	DCLNIWS	Dichlorphenamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Diphenidol + Doxorubicin	DCDV7XS	Diphenidol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Aprepitant	DCVFHMR	Aprepitant	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Pentostatin	DCVR19A	Pentostatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Mebutamate	DCMYVDO	Mebutamate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Picoplatin	DC5IZLH	Picoplatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Baclofen	DCI1I0U	Baclofen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Bepridil	DCITJ2L	Bepridil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Gefitinib	DCTXMS2	Gefitinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Paromomycin	DC6Z8WD	Paromomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Diethylcarbamazine	DCKINST	Diethylcarbamazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Ruxolitinib	DCXCLA6	Ruxolitinib	Hodgkin lymphoma (Cell Line: HDLM-2)	[6]
Doxorubicin + Ruxolitinib	DCTC2FI	Ruxolitinib	Hodgkin lymphoma (Cell Line: L-428)	[6]
Doxorubicin + Ruxolitinib	DCY532Y	Ruxolitinib	T-cell leukemia/lymphoma (Cell Line: ED-40515)	[6]
Doxorubicin + PD-0325901	DC1PM0F	PD-0325901	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + PD-0325901	DC3PZ1F	PD-0325901	Adenocarcinoma (Cell Line: OVCAR3)	[6]
Doxorubicin + PD-0325901	DC776LG	PD-0325901	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + PD-0325901	DCL5V9Y	PD-0325901	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + PD-0325901	DCP8ODG	PD-0325901	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + PD-0325901	DCB7B5H	PD-0325901	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + PD-0325901	DCRMVUE	PD-0325901	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + PD-0325901	DCA1USD	PD-0325901	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + PD-0325901	DC2FWXV	PD-0325901	Adenocarcinoma (Cell Line: SW-620)	[6]
Doxorubicin + PD-0325901	DCI14QR	PD-0325901	Adenocarcinoma (Cell Line: HCT116)	[6]
Doxorubicin + PD-0325901	DC0YQVQ	PD-0325901	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + PD-0325901	DCLHCEX	PD-0325901	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + PD-0325901	DC5047B	PD-0325901	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + PD-0325901	DCX5UAT	PD-0325901	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + PD-0325901	DCAW1EH	PD-0325901	Malignant melanoma (Cell Line: A375)	[6]
Doxorubicin + PD-0325901	DCWRKUL	PD-0325901	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + PD-0325901	DCSXNQO	PD-0325901	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + PD-0325901	DCZ4TO4	PD-0325901	Malignant melanoma (Cell Line: SKMEL30)	[6]
Doxorubicin + PD-0325901	DC24OIX	PD-0325901	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + PD-0325901	DCGH6XJ	PD-0325901	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + PD-0325901	DCUQ7IG	PD-0325901	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + PD-0325901	DCV5W2P	PD-0325901	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + PD-0325901	DC4RR43	PD-0325901	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + PD-0325901	DCS45KD	PD-0325901	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + Citalopram	DC2H7SY	Citalopram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Triamterene	DCO6KBD	Triamterene	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Crotamiton	DC3ANR3	Crotamiton	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Dactinomycin	DC7JI46	Dactinomycin	Hodgkin lymphoma (Cell Line: L-1236)	[6]
Doxorubicin + Lapatinib	DCO1WJY	Lapatinib	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + Lapatinib	DCGCV4L	Lapatinib	Adenocarcinoma (Cell Line: A427)	[6]
Doxorubicin + Lapatinib	DCLJEWA	Lapatinib	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + Lapatinib	DCI024N	Lapatinib	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + Lapatinib	DC4JK9Q	Lapatinib	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + Lapatinib	DCLS5DD	Lapatinib	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + Lapatinib	DCVDI72	Lapatinib	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + Lapatinib	DC5D8I4	Lapatinib	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + Lapatinib	DCS9VHE	Lapatinib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + Lapatinib	DCJK3HJ	Lapatinib	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + Lapatinib	DCBAT0R	Lapatinib	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + Lapatinib	DC9NE70	Lapatinib	Malignant melanoma (Cell Line: UACC62)	[6]
Doxorubicin + Lapatinib	DC1YZXS	Lapatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Epinephrine	DC8PX6M	Epinephrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Tindamax	DCM941G	Tindamax	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Furazolidone	DCFXIS2	Furazolidone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + MK-1775	DCUP72V	MK-1775	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + MK-1775	DCHIOXR	MK-1775	Hodgkin lymphoma (Cell Line: U-HO1)	[6]
Doxorubicin + MK-1775	DC762VA	MK-1775	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + MK-1775	DCNRCTP	MK-1775	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + MK-1775	DCGKX71	MK-1775	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + PMID28460551-Compound-2	DCT3SLV	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + PMID28460551-Compound-2	DCUPEOV	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + PMID28460551-Compound-2	DCX8PWS	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + PMID28460551-Compound-2	DCDVMLQ	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + PMID28460551-Compound-2	DCUR0JR	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + PMID28460551-Compound-2	DC8BMLM	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + PMID28460551-Compound-2	DC99MEM	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HCT116)	[6]
Doxorubicin + PMID28460551-Compound-2	DCMCTHN	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + PMID28460551-Compound-2	DC9JU51	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: SW-620)	[6]
Doxorubicin + PMID28460551-Compound-2	DCUKZEY	PMID28460551-Compound-2	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + PMID28460551-Compound-2	DC5OZWT	PMID28460551-Compound-2	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + PMID28460551-Compound-2	DCELW3O	PMID28460551-Compound-2	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + PMID28460551-Compound-2	DC6K0F3	PMID28460551-Compound-2	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + PMID28460551-Compound-2	DCHPJ58	PMID28460551-Compound-2	Malignant melanoma (Cell Line: A375)	[6]
Doxorubicin + PMID28460551-Compound-2	DCO0LAX	PMID28460551-Compound-2	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + PMID28460551-Compound-2	DCA4N4N	PMID28460551-Compound-2	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + PMID28460551-Compound-2	DCCWVVI	PMID28460551-Compound-2	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + PMID28460551-Compound-2	DCLQYZL	PMID28460551-Compound-2	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + PMID28460551-Compound-2	DCKH544	PMID28460551-Compound-2	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + PMID28460551-Compound-2	DC5XONO	PMID28460551-Compound-2	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + PMID28460551-Compound-2	DCR6OI1	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + PMID28460551-Compound-2	DCF745L	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + Panobinostat	DCBY6TR	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Panobinostat	DCVVEH8	Panobinostat	Hodgkin lymphoma (Cell Line: L-1236)	[6]
Doxorubicin + Methotrexate	DCP4S8K	Methotrexate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Dihydroergotamine	DCUH6A3	Dihydroergotamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Ym155	DCO6TN1	Ym155	Hodgkin lymphoma (Cell Line: L-1236)	[6]
Doxorubicin + Ixazomib	DCRAUAX	Ixazomib	Glioblastoma (Cell Line: JHH-136)	[6]
Doxorubicin + RTB101	DCQI8ID	RTB101	Adenocarcinoma (Cell Line: OVCAR3)	[6]
Doxorubicin + RTB101	DC8262N	RTB101	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + RTB101	DCVRFRI	RTB101	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + RTB101	DCNCF6R	RTB101	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + RTB101	DCSDBS9	RTB101	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + RTB101	DCSKA1B	RTB101	Adenocarcinoma (Cell Line: HCT116)	[6]
Doxorubicin + RTB101	DCTJOFS	RTB101	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + RTB101	DCNFOT4	RTB101	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + RTB101	DCCPH1V	RTB101	Malignant melanoma (Cell Line: A375)	[6]
Doxorubicin + RTB101	DCD1SZV	RTB101	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + RTB101	DCJ0KNW	RTB101	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + RTB101	DC4P4MY	RTB101	Malignant melanoma (Cell Line: UACC62)	[6]
Doxorubicin + RTB101	DCVIXM1	RTB101	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + RTB101	DCFFV31	RTB101	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + RTB101	DCLCLIZ	RTB101	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + RTB101	DCFJBQH	RTB101	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + RTB101	DCYP5LL	RTB101	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + SCH-900776	DCVNOFB	SCH-900776	Adenocarcinoma (Cell Line: OVCAR3)	[6]
Doxorubicin + SCH-900776	DC5GYKZ	SCH-900776	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + SCH-900776	DCA04ZC	SCH-900776	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + SCH-900776	DCR3WPD	SCH-900776	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + SCH-900776	DCCPA86	SCH-900776	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + SCH-900776	DCACY3H	SCH-900776	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + SCH-900776	DCY29RX	SCH-900776	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + SCH-900776	DCORGDA	SCH-900776	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + SCH-900776	DCQIN79	SCH-900776	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + SCH-900776	DCMBUCP	SCH-900776	Malignant melanoma (Cell Line: SKMEL30)	[6]
Doxorubicin + SCH-900776	DCEO81I	SCH-900776	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + SCH-900776	DCR5G9Y	SCH-900776	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + Sivelestat	DCOT50J	Sivelestat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Fomepizole	DCQDY59	Fomepizole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Abexinostat	DC0RJQ6	Abexinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + 10-hydroxycamptothecin	DCCHTXX	10-hydroxycamptothecin	Hodgkin lymphoma (Cell Line: L-1236)	[6]
Doxorubicin + Dronedarone	DC5F51D	Dronedarone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + SNX-2112	DCSYZRK	SNX-2112	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + SNX-2112	DCZF5XW	SNX-2112	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + SNX-2112	DC0CBLL	SNX-2112	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + SNX-2112	DCNLC38	SNX-2112	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + SNX-2112	DCIN1DD	SNX-2112	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + SNX-2112	DC5CVLZ	SNX-2112	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + SNX-2112	DC9WBO5	SNX-2112	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + SNX-2112	DCXJBW3	SNX-2112	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + SNX-2112	DCNPERB	SNX-2112	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + Buspirone	DC48HOS	Buspirone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + SCH 727965	DCTCMNE	SCH 727965	Adenocarcinoma (Cell Line: A427)	[6]
Doxorubicin + SCH 727965	DCK3E2G	SCH 727965	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + SCH 727965	DC7ID6U	SCH 727965	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + SCH 727965	DC7AIX7	SCH 727965	Malignant melanoma (Cell Line: UACC62)	[6]
Doxorubicin + SCH 727965	DCZF6WV	SCH 727965	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Erlotinib	DCXLF43	Erlotinib	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + Erlotinib	DC2XETV	Erlotinib	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + Erlotinib	DCXKCRQ	Erlotinib	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + Erlotinib	DCEK41E	Erlotinib	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + Erlotinib	DCB8VUF	Erlotinib	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + Erlotinib	DCZWI13	Erlotinib	Adenocarcinoma (Cell Line: SW-620)	[6]
Doxorubicin + Erlotinib	DCDE839	Erlotinib	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + Erlotinib	DCDJWLC	Erlotinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + Erlotinib	DCTSRP1	Erlotinib	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + Erlotinib	DCM6Z3B	Erlotinib	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + Erlotinib	DCL9AAL	Erlotinib	Malignant melanoma (Cell Line: UACC62)	[6]
Doxorubicin + Erlotinib	DCZU26H	Erlotinib	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + Erlotinib	DCRLMZV	Erlotinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Triptolide	DCQZUZZ	Triptolide	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Flavonoid derivative 1	DC3DAXR	Flavonoid derivative 1	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Plinabulin	DCB3S91	Plinabulin	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Metformin	DCC04HP	Metformin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Docetaxel	DCBZMXA	Docetaxel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Phenprocoumon	DC2GK7Q	Phenprocoumon	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + LY03004	DCC2PYH	LY03004	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Marizomib	DC9ZTS9	Marizomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Aminosalicylic acid	DCVN2U1	Aminosalicylic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + MK-5108	DCLQEJA	MK-5108	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + MK-5108	DCM5SSN	MK-5108	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + MK-5108	DC5YECW	MK-5108	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + MK-5108	DCTWMU4	MK-5108	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + VR-776	DCDZ9V8	VR-776	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + WAY-100635	DC84HE2	WAY-100635	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Armodafinil	DCBWV85	Armodafinil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Ciprofibrate	DC1509U	Ciprofibrate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Sitagliptin	DCKRU0G	Sitagliptin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Zaleplon	DCDELK1	Zaleplon	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Mitomycin	DCAFB4N	Mitomycin	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + SNDX-275	DCQZLBB	SNDX-275	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Naringenin	DCL4R0G	Naringenin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Clopidogrel	DCO8EKP	Clopidogrel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + PFK-158	DCUTJ7C	PFK-158	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Norcisapride	DCEFNZE	Norcisapride	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Flavopiridol	DC7V6U8	Flavopiridol	Glioblastoma (Cell Line: JHH-136)	[6]
Doxorubicin + Diazoxide	DCH066N	Diazoxide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Ridaforolimus	DC9VTGH	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + Ridaforolimus	DCGXUBO	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + Ridaforolimus	DCBM264	Ridaforolimus	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + Ridaforolimus	DCP9YJC	Ridaforolimus	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + Ridaforolimus	DC089IJ	Ridaforolimus	Adenocarcinoma (Cell Line: HCT116)	[6]
Doxorubicin + Ridaforolimus	DC48ALA	Ridaforolimus	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + Ridaforolimus	DC0DV2Y	Ridaforolimus	Adenocarcinoma (Cell Line: SW-620)	[6]
Doxorubicin + Ridaforolimus	DCM3069	Ridaforolimus	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + Ridaforolimus	DC7AQN9	Ridaforolimus	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[6]
Doxorubicin + Ridaforolimus	DCKBHR7	Ridaforolimus	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + Ridaforolimus	DCUJSE8	Ridaforolimus	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + Ridaforolimus	DCY8S0H	Ridaforolimus	Malignant melanoma (Cell Line: SKMEL30)	[6]
Doxorubicin + Ridaforolimus	DC5PWCB	Ridaforolimus	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + Ridaforolimus	DC20GV1	Ridaforolimus	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + Ridaforolimus	DCGK93L	Ridaforolimus	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Ridaforolimus	DCWB7QG	Ridaforolimus	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + Ridaforolimus	DC45DWA	Ridaforolimus	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + Ridaforolimus	DC4L0BQ	Ridaforolimus	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + Benserazide	DCTPXL9	Benserazide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + MK-4827	DCRGB95	MK-4827	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + MK-4827	DCOMWBQ	MK-4827	Adenocarcinoma (Cell Line: A427)	[6]
Doxorubicin + MK-4827	DCQQNWT	MK-4827	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + MK-4827	DC9UG3A	MK-4827	Adenocarcinoma (Cell Line: NCIH520)	[6]
Doxorubicin + MK-4827	DCI35U2	MK-4827	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + MK-4827	DCZSZU1	MK-4827	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + MK-4827	DCATWSC	MK-4827	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + MK-4827	DCVIH8G	MK-4827	Adenocarcinoma (Cell Line: SW-620)	[6]
Doxorubicin + MK-4827	DCHFJ3S	MK-4827	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + MK-4827	DCZ15QI	MK-4827	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + MK-4827	DCRJXWQ	MK-4827	Malignant melanoma (Cell Line: A375)	[6]
Doxorubicin + MK-4827	DCMVI08	MK-4827	Malignant melanoma (Cell Line: HT144)	[6]
Doxorubicin + MK-4827	DCUBP8K	MK-4827	Malignant melanoma (Cell Line: SKMEL30)	[6]
Doxorubicin + MK-4827	DCZLRWQ	MK-4827	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + MK-4827	DCU9CZC	MK-4827	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + MK-4827	DCXDLIS	MK-4827	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + MK-4827	DCRH8TS	MK-4827	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + MK-4827	DCYIV0Q	MK-4827	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + MK-4827	DC4GMC5	MK-4827	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + Idarubicin	DC3H0I2	Idarubicin	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + Idarubicin	DCFAJLH	Idarubicin	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + Idarubicin	DCAUCE0	Idarubicin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Methocarbamol	DC7X2OY	Methocarbamol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + ONC201	DCTCJOV	ONC201	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Imatinib	DCKEUS7	Imatinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Abacavir	DCNX52S	Abacavir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Nintedanib	DCC9CUP	Nintedanib	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + Darunavir	DC8T8XK	Darunavir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Resminostat	DCWB76N	Resminostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Bortezomib	DCHVKYG	Bortezomib	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + Bortezomib	DCQ9KHO	Bortezomib	Amelanotic melanoma (Cell Line: A2058)	[6]
Doxorubicin + Bortezomib	DCCXR00	Bortezomib	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + Bortezomib	DCEMI5S	Bortezomib	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + Bortezomib	DCD5RVT	Bortezomib	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + Bortezomib	DCP1J99	Bortezomib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Bortezomib	DCZWWZ3	Bortezomib	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + Bortezomib	DC7CYV2	Bortezomib	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + Tropisetron	DCWYLQQ	Tropisetron	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Acamprosate	DCZ4SK7	Acamprosate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Ethinyl estradiol	DCH1LWA	Ethinyl estradiol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Artemisinin	DCIMWIU	Artemisinin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + GSK525762	DCYVVXM	GSK525762	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Olanzapine	DCF9TY1	Olanzapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Clascoterone	DC3CRDS	Clascoterone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Dopamine	DCU1XD0	Dopamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + BMS-754807	DCBBM2L	BMS-754807	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Cefmenoxime	DCT0B7G	Cefmenoxime	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Maprotiline	DCIV7P1	Maprotiline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Citarinostat	DCP297X	Citarinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + KU-0060648	DC6HOAE	KU-0060648	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + Acetohexamide	DCQ4T5C	Acetohexamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Leflunomide	DCHNG8A	Leflunomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Theophylline	DCEC0FA	Theophylline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Bumetanide	DC45E8S	Bumetanide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + PHA848125	DC4TVZN	PHA848125	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Amantadine	DC1CQY2	Amantadine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Valproic Acid	DCX57WN	Valproic Acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Sorafenib	DC4N4XB	Sorafenib	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + Sorafenib	DCI1TWJ	Sorafenib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Sorafenib	DCLY6OR	Sorafenib	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + Sorafenib	DCBL077	Sorafenib	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + Sorafenib	DCR1VEV	Sorafenib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Desoxycorticosterone pivalate	DC0ZS1T	Desoxycorticosterone pivalate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + PF-562271	DCXZWVE	PF-562271	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + Quinine	DCH819O	Quinine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + MK-2206	DCF0N64	MK-2206	Adenocarcinoma (Cell Line: A427)	[6]
Doxorubicin + MK-2206	DC1BCDA	MK-2206	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + MK-2206	DC41SZ3	MK-2206	Adenocarcinoma (Cell Line: NCIH2122)	[6]
Doxorubicin + MK-2206	DCXEBXO	MK-2206	Adenocarcinoma (Cell Line: NCIH23)	[6]
Doxorubicin + MK-2206	DCY1TI9	MK-2206	Adenocarcinoma (Cell Line: COLO320DM)	[6]
Doxorubicin + MK-2206	DCOYPEI	MK-2206	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + MK-2206	DCR4WA1	MK-2206	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + MK-2206	DCNNII9	MK-2206	Large cell lung carcinoma (Cell Line: NCI-H460)	[6]
Doxorubicin + MK-2206	DCFQU9I	MK-2206	Malignant melanoma (Cell Line: RPMI7951)	[6]
Doxorubicin + MK-2206	DCNA0DR	MK-2206	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + MK-2206	DCFTRBB	MK-2206	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + MK-2206	DC4CK76	MK-2206	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + MK-2206	DC30IYX	MK-2206	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + MK-2206	DCG3QXK	MK-2206	Prostate carcinoma (Cell Line: LNCAP)	[6]
Doxorubicin + MK-2206	DCFN442	MK-2206	Prostate carcinoma (Cell Line: VCAP)	[6]
Doxorubicin + Spironolactone	DCB2AJW	Spironolactone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + CHS-828	DC4CWGL	CHS-828	Ewing sarcoma (Cell Line: TC-71)	[6]
Doxorubicin + Endoxifen	DCNS6TN	Endoxifen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Hydralazine	DC4Q8HB	Hydralazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Doxorubicin	DCNJHMM	Doxorubicin	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + Zileuton	DCSDV48	Zileuton	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Silver sulfadiazine	DCTH6YR	Silver sulfadiazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Sumatriptan	DCUQ93N	Sumatriptan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Cerivastatin	DCWS4WS	Cerivastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Metaxalone	DC1TWXV	Metaxalone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Hydroxychloroquine	DC9SFS4	Hydroxychloroquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Atovaquone	DCCLH0Q	Atovaquone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + CB3304	DCGRKOY	CB3304	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Doxorubicin + Aciclovir	DC2LQNH	Aciclovir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Acetohydroxamic Acid	DCF0RX8	Acetohydroxamic Acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Sapanisertib	DCBZ2BF	Sapanisertib	Hodgkin lymphoma (Cell Line: L-1236)	[6]
Doxorubicin + Ibrutinib	DC5VD8M	Ibrutinib	Diffuse large B cell lymphoma (Cell Line: TMD8)	[6]
Doxorubicin + GSK2194069	DCP8SA0	GSK2194069	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Dasatinib	DCS9EC4	Dasatinib	Adenocarcinoma (Cell Line: CAOV3)	[6]
Doxorubicin + Dasatinib	DC57RVZ	Dasatinib	Adenocarcinoma (Cell Line: OVCAR3)	[6]
Doxorubicin + Dasatinib	DCYO57R	Dasatinib	Adenocarcinoma (Cell Line: NCIH1650)	[6]
Doxorubicin + Dasatinib	DC14EJC	Dasatinib	Adenocarcinoma (Cell Line: DLD1)	[6]
Doxorubicin + Dasatinib	DCR7G0R	Dasatinib	Adenocarcinoma (Cell Line: HT29)	[6]
Doxorubicin + Dasatinib	DCKQ760	Dasatinib	Germ cell tumour (Cell Line: PA1)	[6]
Doxorubicin + Dasatinib	DCGLAOE	Dasatinib	Mesothelioma (Cell Line: MSTO)	[6]
Doxorubicin + Dasatinib	DCTY93C	Dasatinib	Non small cell carcinoma (Cell Line: SKMES1)	[6]
Doxorubicin + Dasatinib	DCD59EM	Dasatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[6]
Doxorubicin + Dasatinib	DCHAC5B	Dasatinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[6]
Doxorubicin + Etomidate	DCCPC2K	Etomidate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + Cilostazol	DC5AMHU	Cilostazol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Doxorubicin + PD-0325901	DCV7V4A	PD-0325901	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + PD-0325901	DCX196W	PD-0325901	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + PD-0325901	DCMVPVF	PD-0325901	Carcinoma (Cell Line: EFM192B)	[8]
Doxorubicin + PD-0325901	DC5RDA5	PD-0325901	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + PD-0325901	DCE0ETS	PD-0325901	Colon carcinoma (Cell Line: RKO)	[8]
Doxorubicin + PD-0325901	DCB7OEP	PD-0325901	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + PD-0325901	DC74XPA	PD-0325901	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + Lapatinib	DCK9UCK	Lapatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + Lapatinib	DC6ALBR	Lapatinib	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + Lapatinib	DCEL7MG	Lapatinib	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + Lapatinib	DCXAKAZ	Lapatinib	Colon carcinoma (Cell Line: RKO)	[8]
Doxorubicin + Lapatinib	DC3YOS8	Lapatinib	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + Lapatinib	DCKPCU6	Lapatinib	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + PMID28460551-Compound-2	DCWMFDR	PMID28460551-Compound-2	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[8]
Doxorubicin + PMID28460551-Compound-2	DCV358Y	PMID28460551-Compound-2	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + PMID28460551-Compound-2	DCAK5V5	PMID28460551-Compound-2	Breast carcinoma (Cell Line: ZR751)	[8]
Doxorubicin + PMID28460551-Compound-2	DC1C277	PMID28460551-Compound-2	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + PMID28460551-Compound-2	DCO78OB	PMID28460551-Compound-2	Carcinoma (Cell Line: OV90)	[8]
Doxorubicin + PMID28460551-Compound-2	DCKC6T0	PMID28460551-Compound-2	Carcinoma (Cell Line: EFM192B)	[8]
Doxorubicin + PMID28460551-Compound-2	DCQGOS7	PMID28460551-Compound-2	Carcinoma (Cell Line: MDAMB436)	[8]
Doxorubicin + PMID28460551-Compound-2	DCIU8DF	PMID28460551-Compound-2	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + PMID28460551-Compound-2	DCPGXUR	PMID28460551-Compound-2	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + RTB101	DCGY4D1	RTB101	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[8]
Doxorubicin + RTB101	DC3Z1A5	RTB101	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + RTB101	DCX2CZC	RTB101	Breast carcinoma (Cell Line: ZR751)	[8]
Doxorubicin + RTB101	DC54VCW	RTB101	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + RTB101	DCHMLTV	RTB101	Carcinoma (Cell Line: EFM192B)	[8]
Doxorubicin + RTB101	DC6EB43	RTB101	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + RTB101	DC5884J	RTB101	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + SCH-900776	DCY6SEL	SCH-900776	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[8]
Doxorubicin + SCH-900776	DCCVD13	SCH-900776	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + SNX-2112	DCARSCT	SNX-2112	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + SCH 727965	DCSAXHR	SCH 727965	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + Erlotinib	DC77W5I	Erlotinib	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + Erlotinib	DCQHT53	Erlotinib	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + Erlotinib	DCL79LZ	Erlotinib	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + Ridaforolimus	DCDGCGX	Ridaforolimus	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + Ridaforolimus	DC075OH	Ridaforolimus	Breast carcinoma (Cell Line: ZR751)	[8]
Doxorubicin + Ridaforolimus	DCUKI2Z	Ridaforolimus	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + Ridaforolimus	DC5NT18	Ridaforolimus	Carcinoma (Cell Line: EFM192B)	[8]
Doxorubicin + Ridaforolimus	DCTTROD	Ridaforolimus	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + Ridaforolimus	DCRYRQ4	Ridaforolimus	Colon carcinoma (Cell Line: RKO)	[8]
Doxorubicin + Ridaforolimus	DCNMJDD	Ridaforolimus	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + MK-4827	DCTYHPR	MK-4827	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + MK-4827	DCVEGLJ	MK-4827	Breast carcinoma (Cell Line: ZR751)	[8]
Doxorubicin + MK-4827	DC8H7CJ	MK-4827	Breast carcinoma (Cell Line: KPL1)	[8]
Doxorubicin + MK-4827	DCS0V2H	MK-4827	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + MK-4827	DCMJ1DT	MK-4827	Carcinoma (Cell Line: EFM192B)	[8]
Doxorubicin + MK-4827	DCT8G89	MK-4827	Colon carcinoma (Cell Line: RKO)	[8]
Doxorubicin + MK-4827	DC30CBW	MK-4827	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + MK-4827	DCBJWXJ	MK-4827	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + Bortezomib	DCI1EJ5	Bortezomib	Breast carcinoma (Cell Line: ZR751)	[8]
Doxorubicin + Bortezomib	DCDTAZY	Bortezomib	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + Bortezomib	DCIUZI6	Bortezomib	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + Bortezomib	DC9RQWM	Bortezomib	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Doxorubicin + GSK525762	DCY35CU	GSK525762	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + MK-2206	DCOVF0J	MK-2206	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Doxorubicin + MK-2206	DCCNRTQ	MK-2206	Breast carcinoma (Cell Line: KPL1)	[8]
Doxorubicin + MK-2206	DC2I0ZU	MK-2206	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + MK-2206	DC23DK1	MK-2206	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + Dasatinib	DCM7I0W	Dasatinib	Breast carcinoma (Cell Line: OCUBM)	[8]
Doxorubicin + Dasatinib	DCI6EYL	Dasatinib	Colon adenocarcinoma (Cell Line: LOVO)	[8]
Doxorubicin + Dasatinib	DC4LURL	Dasatinib	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Doxorubicin + Dasatinib	DCU46SH	Dasatinib	Rectal adenocarcinoma (Cell Line: SW837)	[8]
Efavirenz + Doxorubicin	DC31M2X	Efavirenz	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Eflornithine + Doxorubicin	DC8YBPH	Eflornithine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Enoxacin + Doxorubicin	DCX1H12	Enoxacin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Erlotinib + Doxorubicin	DCSCMCP	Erlotinib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Estramustine + Doxorubicin	DC51LQ7	Estramustine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Ethambutol + Doxorubicin	DCX72GR	Ethambutol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Etoposide + Doxorubicin	DCDUJDF	Etoposide	Ewing sarcoma (Cell Line: TC-71)	[6]
Everolimus + Doxorubicin	DC36WVF	Everolimus	Ewing sarcoma (Cell Line: TC-71)	[6]
Exherin + Doxorubicin	DC1MQZ5	Exherin	Ewing sarcoma (Cell Line: TC-71)	[6]
Ezetimibe + Doxorubicin	DCHYZ2R	Ezetimibe	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Fenoprofen + Doxorubicin	DCZUCTG	Fenoprofen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Fibrates + Doxorubicin	DC16YHZ	Fibrates	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Fluorouracil + Doxorubicin	DC58VZO	Fluorouracil	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[8]
Fluorouracil + Doxorubicin	DC6YBB6	Fluorouracil	Invasive ductal carcinoma (Cell Line: T-47D)	[8]
Fluorouracil + Doxorubicin	DC061HP	Fluorouracil	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Doxorubicin	DCNNR32	Fluorouracil	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Doxorubicin	DCK13WM	Fluorouracil	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Doxorubicin	DC5XC55	Fluorouracil	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Doxorubicin	DC1UYX0	Fluorouracil	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Doxorubicin	DC0QZAW	Fluorouracil	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Doxorubicin	DCW8KS7	Fluorouracil	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Doxorubicin	DCLM2U9	Fluorouracil	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Doxorubicin	DCMR0KB	Fluorouracil	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
GDC-0084 + Doxorubicin	DCXIUC5	GDC-0084	Ewing sarcoma (Cell Line: TC-71)	[6]
GINKGOLIDE A + Doxorubicin	DCR9G30	GINKGOLIDE A	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Hydralazine + Doxorubicin	DCGVU7C	Hydralazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Ibutilide + Doxorubicin	DC491O9	Ibutilide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Idarubicin + Doxorubicin	DCE15PL	Idarubicin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Isosorbide dinitrate + Doxorubicin	DCB453Z	Isosorbide dinitrate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Itraconazole + Doxorubicin	DCOHRE8	Itraconazole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
JZL195 + Doxorubicin	DC6SWY7	JZL195	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
K-134 + Doxorubicin	DCLIND6	K-134	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Kanamycin + Doxorubicin	DC2U4OP	Kanamycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
L-165041 + Doxorubicin	DCDFGE8	L-165041	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Lacosamide + Doxorubicin	DCZHVR8	Lacosamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Lenalidomide + Doxorubicin	DCJALP5	Lenalidomide	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Levamisole + Doxorubicin	DCPAV25	Levamisole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Loperamide + Doxorubicin	DCAIF8X	Loperamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Lubiprostone + Doxorubicin	DCPF6N8	Lubiprostone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Lumefantrine + Doxorubicin	DCN673Y	Lumefantrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
LY2835219 + Doxorubicin	DC0Y4RQ	LY2835219	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Mebutamate + Doxorubicin	DCCMG5N	Mebutamate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Mephenytoin + Doxorubicin	DCGLCEB	Mephenytoin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Mesalazine + Doxorubicin	DCYW81C	Mesalazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Mitomycin + Doxorubicin	DCZ0LQS	Mitomycin	Hodgkin lymphoma (Cell Line: L-1236)	[7]
MK-1775 + Doxorubicin	DCLAEWE	MK-1775	Ewing sarcoma (Cell Line: TC-71)	[6]
MK-2206 + Doxorubicin	DCE1TSM	MK-2206	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
ML323 + Doxorubicin	DCG0UCS	ML323	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Moricizine + Doxorubicin	DC0MD15	Moricizine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Naltrexone + Doxorubicin	DCONUHN	Naltrexone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Nitisinone + Doxorubicin	DCLFF2J	Nitisinone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Nitrosoglutathione + Doxorubicin	DCPB02Q	Nitrosoglutathione	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Nizatidine + Doxorubicin	DCBVITL	Nizatidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Novobiocin + Doxorubicin	DCYVHEL	Novobiocin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
ONC201 + Doxorubicin	DCRBBQ8	ONC201	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[6]
Palonosetron + Doxorubicin	DCU53ER	Palonosetron	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Panobinostat + Doxorubicin	DCTXOZJ	Panobinostat	Ewing sarcoma (Cell Line: TC-71)	[6]
Panobinostat + Doxorubicin	DCAV0C3	Panobinostat	Hodgkin lymphoma (Cell Line: HDLM-2)	[7]
Pargyline + Doxorubicin	DC5V9Z2	Pargyline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pazopanib + Doxorubicin	DCASV72	Pazopanib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pentamidine + Doxorubicin	DCCSQL4	Pentamidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pepstatin + Doxorubicin	DCQ5H29	Pepstatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
PF-02545920 + Doxorubicin	DCW15R1	PF-02545920	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
PHA-739358 + Doxorubicin	DCKJ6NI	PHA-739358	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pizotyline + Doxorubicin	DCBBQDG	Pizotyline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
PMID28460551-Compound-2 + Doxorubicin	DC4EVUY	PMID28460551-Compound-2	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pomalidomide + Doxorubicin	DCSWMUO	Pomalidomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Pramipexole + Doxorubicin	DCUJX0Q	Pramipexole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Primidone + Doxorubicin	DCCCFC9	Primidone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Raltegravir + Doxorubicin	DCK7680	Raltegravir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Repaglinide + Doxorubicin	DCODYR9	Repaglinide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Ribavirin-TP + Doxorubicin	DC04OHP	Ribavirin-TP	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Romidepsin + Doxorubicin	DCYEV3M	Romidepsin	Ewing sarcoma (Cell Line: TC-71)	[6]
Rufinamide + Doxorubicin	DCJSYEU	Rufinamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Sulfinpyrazone + Doxorubicin	DC4T8EJ	Sulfinpyrazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Tamoxifen + Doxorubicin	DCQ4SKN	Tamoxifen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Terameprocol + Doxorubicin	DC869VC	Terameprocol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Testosterone + Doxorubicin	DC3WPFY	Testosterone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Testosterone cypionate + Doxorubicin	DCOCBJH	Testosterone cypionate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Tetracycline + Doxorubicin	DCCAJNU	Tetracycline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
THAPSIGARGIN + Doxorubicin	DCSTQVR	THAPSIGARGIN	Ewing sarcoma (Cell Line: TC-71)	[6]
Tolazoline + Doxorubicin	DCXFOXX	Tolazoline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Tolvaptan + Doxorubicin	DCLSFL2	Tolvaptan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Topetecan + Doxorubicin	DCFYI7I	Topetecan	Glioblastoma (Cell Line: JHH-136)	[6]
Trifluoperazine + Doxorubicin	DCLVC6H	Trifluoperazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Triflupromazine + Doxorubicin	DCY5CSF	Triflupromazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Triiodothyronine + Doxorubicin	DCC34S8	Triiodothyronine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Trimethobenzamide + Doxorubicin	DCHZ2Z3	Trimethobenzamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Trioxsalen + Doxorubicin	DCHWLSD	Trioxsalen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Vinblastine + Doxorubicin	DC0HPIN	Vinblastine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
Vorinostat + Doxorubicin	DCLKZUN	Vorinostat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 493 DrugCom(s)

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Bortezomib + Doxorubicin	DC2Q6F4	Bortezomib	Multiple Myeloma	[9]
Dexrazoxane + Doxorubicin	DC0C2N6	Dexrazoxane	Sarcoma, Soft Tissue	[10]
Lurbinectedin + Doxorubicin	DCW7PJ4	Lurbinectedin	Metastatic Sarcoma	[11]
------------------------------------------------------------------------------------

References

1	Doxorubicin FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7069).
3	ClinicalTrials.gov (NCT02112656) Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) (OPTIMA). U.S. National Institutes of Health.
4	Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J Natl Cancer Inst. 1990 Nov 7;82(21):1706-10.
5	Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
6	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
7	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
8	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
9	ClinicalTrials.gov (NCT00103506) Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
10	ClinicalTrials.gov (NCT02584309) Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
11	ClinicalTrials.gov (NCT02448537) A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas